NeuroCores, Inc. is a preclinical biotech company that is revolutionizing the treatment of rare pediatric diseases.Our lead asset is KIT-13, a novel oral small molecule drug targeting Rett Syndrome, a rare genetic neurological disorder.NeuroCores is ...